Curcumin Inhibits Protein Kinase C? Activity by Binding to Its C1 Domain.
Ontology highlight
ABSTRACT: Curcumin is a polyphenolic nutraceutical that acts on multiple biological targets, including protein kinase C (PKC). PKC is a family of serine/threonine kinases central to intracellular signal transduction. We have recently shown that curcumin selectively inhibits PKC?, but not PKC?, in CHO-K1 cells [Pany, S. (2016) Biochemistry 55, 2135-2143]. To understand which domain(s) of PKC? is responsible for curcumin binding and inhibitory activity, we made several domain-swapped mutants in which the C1 (combination of C1A and C1B) and C2 domains are swapped between PKC? and PKC?. Phorbol ester-induced membrane translocation studies using confocal microscopy and immunoblotting revealed that curcumin inhibited phorbol ester-induced membrane translocation of PKC? mutants, in which the ?C1 domain was replaced with ?C1, but not the PKC? mutant in which ?C1 was replaced with the ?C1 domain, suggesting that ?C1 is a determinant for curcumin's inhibitory effect. In addition, curcumin inhibited membrane translocation of PKC? mutants, in which the ?C1A and ?C1B domains were replaced with the ?C1A and ?C1B domains, respectively, indicating the role of both ?C1A and ?C1B domains in curcumin's inhibitory effects. Phorbol 13-acetate inhibited the binding of curcumin to ?C1A and ?C1B with IC50 values of 6.27 and 4.47 ?M, respectively. Molecular docking and molecular dynamics studies also supported the higher affinity of curcumin for ?C1B than for ?C1A. The C2 domain-swapped mutants were inactive in phorbol ester-induced membrane translocation. These results indicate that curcumin binds to the C1 domain of PKC? and highlight the importance of this domain in achieving PKC isoform selectivity.
SUBMITTER: Pany S
PROVIDER: S-EPMC5657492 | biostudies-literature | 2016 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA